Title |
Effectiveness of the Coronavirus Disease 2019 (COVID-19) Bivalent Vaccine
|
---|---|
Published in |
medRxiv, December 2022
|
DOI | 10.1101/2022.12.17.22283625 |
Authors |
Nabin K. Shrestha, Patrick C. Burke, Amy S. Nowacki, James F. Simon, Amanda Hagen, Steven M. Gordon |
X Demographics
The data shown below were collected from the profiles of 45,848 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 6233 | 14% |
Brazil | 1377 | 3% |
United Kingdom | 1102 | 2% |
Canada | 1079 | 2% |
Japan | 1076 | 2% |
France | 738 | 2% |
Germany | 421 | <1% |
Australia | 402 | <1% |
Spain | 392 | <1% |
Other | 3179 | 7% |
Unknown | 29849 | 65% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 44276 | 97% |
Practitioners (doctors, other healthcare professionals) | 662 | 1% |
Scientists | 554 | 1% |
Science communicators (journalists, bloggers, editors) | 298 | <1% |
Unknown | 58 | <1% |